Keywords: boston, sci, taxus, gains, expedited, fda, review

Boston Sci's Taxus gains expedited FDA review

Article | 24 March 2003

Print This

Boston Scientific says it has been notified by the US Food and DrugAdministration that its Taxus (paclitaxel-eluting coronary stent) has ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in